Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
825.00    8.00 (0.98%)
Bid:
823.00
Ask:
825.00
Spread: 2.00 (0.243%)
Market Cap: £1.14b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Interim Management Statement

12 May 2014 11:02

RNS Number : 8360G
Savills PLC
12 May 2014
 



 

12 May 2014

 

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement and Interim Management Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 33 Margaret Street, London, W1G 0JD, and provides the following Interim Management Statement (IMS) for the period to 12 May 2014.

 

During the first four months of the year Savills has traded as anticipated with continued growth in the UK, and a robust performance in both Asia and Continental Europe. Our US business has an improved pipeline and Cordea Savills, the Group's investment management business, has traded in line with our expectations of revenue and profit growth.

 

In the UK commercial markets Savills has continued to maintain a significant share of the Prime Central London investment and leasing markets, although, as anticipated, the shortage of supply of investment stock has become increasingly apparent. Growth in investment volume outside London has continued from last year and development activity has further increased. We continue to expect regional recovery to be the primary driver of growth for our UK commercial business in 2014.

 

The UK Prime Residential market has continued to perform well with year on year increases in both volume and value. As anticipated, we have lately seen some cooling in the Prime and Super Prime Central London market. In contrast, there remains strong demand for property in the £1 million-£2 million price segments of the North, East and South West London regions. The regional UK residential market is continuing to recover with growing volumes and a significant increase in buyers registering with Savills.

 

In Asia Pacific, allowing for the material fall in trading volumes in Hong Kong in comparison with the same period last year, business has performed in line with expectations. Our Japanese business has continued to grow substantially as a result of the sustained strength of the Tokyo commercial investment market during the period. In mainland China, despite a slow down in transaction markets, revenue and earnings have grown in line with our expectations thanks to the growth of our Property Management business.

 

In Continental Europe, to date we have traded in line with our expectations, with strengthening performance in the transaction markets of Ireland, Spain, Germany and France.

 

Globally, our Consultancy business has experienced continued revenue growth with particular strengths in UK Development consultancy and UK/Continental European Valuation consultancy. The Property Management business has delivered a solid increase in revenue, particularly in the UK and in Asia where we continued to grow our market share in the core markets of Hong Kong and China.

 

Following a strong year of capital raising in 2013, Cordea Savills has grown revenue and profits in line with our expectations for the period to date, whilst continuing to experience significant capital inflows.

 

In the US, the existing Savills business has performed in line with expectations and our proposed acquisition of Studley Inc. was unanimously approved at the Studley Stockholder meeting held yesterday. Pending expiry of the Hart-Scott-Rodino Antitrust notification period, it is anticipated that the transaction will be completed on 30th May 2014.

 

 

For further information, contact:

 

Savills 020 7409 8934

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Peter Hewer

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAESAFEFLEFF
Date   Source Headline
2nd Dec 202410:00 amRNSTotal Voting Rights
26th Nov 20243:34 pmRNSHolding(s) in Company
22nd Nov 20242:00 pmRNSAdditional Listing
15th Nov 20242:58 pmRNSHolding(s) in Company
14th Nov 20241:53 pmRNSHolding(s) in Company
13th Nov 20241:47 pmRNSHolding(s) in Company
12th Nov 20242:51 pmRNSDirector/PDMR Shareholding
12th Nov 20242:48 pmRNSHolding(s) in Company
11th Nov 20242:25 pmRNSHolding(s) in Company
1st Nov 202411:00 amRNSTotal Voting Rights
14th Oct 20249:52 amRNSDirector/PDMR Shareholding
4th Oct 20242:00 pmRNSAdditional Listing
1st Oct 202411:00 amRNSTotal Voting Rights
18th Sep 20242:43 pmRNSDirector Declaration
16th Sep 20243:50 pmRNSDirector Declaration
12th Sep 20241:47 pmRNSDirector/PDMR Shareholding
2nd Sep 202411:00 amRNSTotal Voting Rights
29th Aug 20242:24 pmRNSDirector/PDMR Shareholding
15th Aug 202411:00 amRNSBlock listing Interim Review
13th Aug 20243:17 pmRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNSHalf-year Report
1st Aug 202411:00 amRNSTotal Voting Rights
30th Jul 20242:11 pmRNSHolding(s) in Company
22nd Jul 20242:36 pmRNSBlock listing Interim Review
11th Jul 20244:26 pmRNSDirector/PDMR Shareholding
1st Jul 20249:27 amRNSTotal Voting Rights
20th Jun 202410:36 amRNSDirector/PDMR Shareholding
13th Jun 20241:37 pmRNSDirector/PDMR Shareholding
11th Jun 20244:42 pmRNSDirector/PDMR Shareholding
7th Jun 20244:01 pmRNSDirector/PDMR Shareholding
4th Jun 20242:43 pmRNSDirector/PDMR Shareholding
3rd Jun 202411:00 amRNSTotal Voting Rights
23rd May 20242:21 pmRNSDirector/PDMR Shareholding
17th May 20243:44 pmRNSDirector/PDMR Shareholding
15th May 20243:06 pmRNSResult of AGM
15th May 202410:02 amRNSAGM Statement
14th May 20248:00 amRNSDirector/PDMR Shareholding
2nd May 20248:28 amRNSTotal Voting Rights
26th Apr 20242:13 pmRNSDirector/PDMR Shareholding
26th Apr 202411:21 amRNSDirector Declaration
15th Apr 20243:42 pmRNSDirector/PDMR Shareholding
12th Apr 20245:12 pmRNSDirector/PDMR Shareholding
8th Apr 20243:47 pmRNSAnnual Report and AGM Notice
21st Mar 20248:17 amRNSDirector/PDMR Shareholding
19th Mar 20245:11 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSNon-Executive Director Appointment
14th Mar 20247:00 amRNSFinal Results
13th Mar 20241:37 pmRNSDirector/PDMR Shareholding
15th Feb 202410:00 amRNSBlock listing Interim Review
13th Feb 20246:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.